➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Moodys
McKinsey
Merck

Last Updated: July 14, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209476


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 209476 describes SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Baxter Hlthcare, and Fresenius Kabi Usa, and is included in three NDAs. It is available from four suppliers. Additional details are available on the SODIUM CHLORIDE 3% IN PLASTIC CONTAINER profile page.

The generic ingredient in SODIUM CHLORIDE 3% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 209476
Tradename:SODIUM CHLORIDE 3% IN PLASTIC CONTAINER
Applicant:Fresenius Kabi Usa
Ingredient:sodium chloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 209476
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM CHLORIDE 3% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 209476 ANDA Becton Dickinson and Company 17271-703 17271-703-06 20 BAG in 1 CASE (17271-703-06) > 500 mL in 1 BAG
SODIUM CHLORIDE 3% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 209476 ANDA Fresenius Kabi USA, LLC 63323-530 63323-530-75 20 BAG in 1 CASE (63323-530-75) > 500 mL in 1 BAG (63323-530-21)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3GM/100ML
Approval Date:Mar 13, 2019TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
Moodys
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.